Fluciclovine is a potential imaging biomarker of glutamine utilisation in breast cancer
Prif Awduron: | Teoh, EJ, Bridges, EM, Morotti, M, Zois, CE, Lord, SR, Gleeson, FV, Harris, AL |
---|---|
Fformat: | Conference item |
Iaith: | English |
Cyhoeddwyd: |
Springer
2017
|
Eitemau Tebyg
-
Fluciclovine (F-18) is a marker for high-affinity glutamine transporter ASCT2-mediated amino acid transport in breast cancer
gan: Teoh, E, et al.
Cyhoeddwyd: (2017) -
Characterising ¹⁸F-fluciclovine uptake in breast cancer through the use of dynamic PET/CT imaging
gan: Scott, NP, et al.
Cyhoeddwyd: (2021) -
Cancer imaging with fluciclovine (18F)
gan: Teoh, E
Cyhoeddwyd: (2018) -
Increased expression of glutamine transporter SNAT2/SLC38A2 promotes glutamine dependence and oxidative stress resistance, and is associated with worse prognosis in triple-negative breast cancer
gan: Morotti, M, et al.
Cyhoeddwyd: (2020) -
Glutamine deprivation alters the origin and function of cancer cell exosomes
gan: Fan, S, et al.
Cyhoeddwyd: (2020)